1.A Study on the Anti-smallpox Policy of Joseon Government-General.
Korean Journal of Medical History 2012;21(3):377-402
In the beginning of the colonial era, the Joseon Government-General's most important medical policy was related to the disease of smallpox. The Government-General reused some of policies established by the Great Han Empire. They also made an effort to improve the shortcomings in that anti-smallpox policy by phasing out technically insufficient vaccinators and by incubating female vaccinators. However, compulsory vaccination was the major component of the Government-General's anti-smallpox policy. The vaccination effort was lead by police officers and the frequency of vaccinations was increased two-fold. When the anti-smallpox policy became effective in 1910, the incidence of smallpox decreased. However, after 1919, the incidence of smallpox began to increase once more. According to the Government-General, this increase was the result of a decrease in the frequency of vaccinations. Therefore, in 1923, the Government-General increased the frequency of vaccinations from twice to three times by implementing the Joseon Cowpox Ordinance. Under this policy adults were also vaccinated. Interventions by local organizations were also expanded. However, through the end of the colonial era, smallpox never fully disappeared in Joseon. The lower-than-expected rate of vaccination has been identified as one of important reasons for the constant presence of this pathogenesis. Incomplete census registration was identified as the major reason for the decrease in the vaccination rate. Insufficient technologies for disseminating the smallpox vaccine and ambiguity with regard to the vaccine's effectiveness also prevented the people of Joseon from voluntarily obtaining their vaccinations. To increase the rate of vaccination, it was necessary to secure the cooperation of Koreans. However, that cooperation has never been harmonious. No records exist of any discussions related to the problem of smallpox or the effect of the anti-smallpox vaccination, which was a reasonable expectation for the citizens of Joseon. Moreover, the Government-General kept insisting that the Joseon citizens' ideas about the need for sanitary and effective vaccinations were insufficient. The sought-after cooperation was never easy, and this resulted in the extensive duration of outbreaks of smallpox.
Adult
;
Censuses
;
Cowpox
;
Disease Outbreaks
;
Female
;
Humans
;
Incidence
;
Police
;
Smallpox
;
Smallpox Vaccine
;
Vaccination
2.Research progress on the effectiveness of smallpox vaccination against mpox virus infection.
Yun Shao XU ; Ming Yue JIANG ; Yan Lin CAO ; Yan Xia SUN ; Qiang Ru HUANG ; Wei Zhong YANG ; Lu Zhao FENG
Chinese Journal of Epidemiology 2023;44(4):673-676
With the expansion of mpox virus infection from endemic to a global epidemic in 2022, the WHO declared that the mpox event constituted a Public Health Emergency of International Concern. Due to the high degree of gene sequence similarity among orthopox viruses and cross-reactive antibodies induced by orthoviruses, smallpox vaccination may affect the immune response induced by mpox virus infection. The analysis of the protective effects of smallpox vaccination against mpox virus infection will help define the focus of prevention and control. In this review, we clarify the protection of the smallpox vaccine against mpox virus infection by analyzing the correlation between smallpox vaccination, immune response status, and clinical data and providing evidence for the prevention, control, and strategies of mpox epidemics.
Humans
;
Smallpox/epidemiology*
;
Monkeypox/drug therapy*
;
Smallpox Vaccine/therapeutic use*
;
Vaccination
;
Immunity
3.Immune control strategies for vaccinia virus-related laboratory-acquired infections.
Qiang WEI ; Meng Nan JIANG ; Jun HAN ; Zi Jun WANG
Biomedical and Environmental Sciences 2014;27(2):142-146
While presenting biological characteristics of vaccinia virus and laboratory-acquired infections during related research processes, this paper focuses on benefits and risks of vaccinia virus immunization in relation to laboratory-acquired infections, describes characteristics and the adaptation of vaccinia virus vaccine, analyses the role vaccinia virus immunization plays in the prevention and control of laboratory-acquired infections, and finally proposes solutions and countermeasures to further promote and implement immune control strategies. The problem related to immune strategy and laboratory- acquired infections which is being raised, analyzed and explored plays an active and instructive role in vaccinia virus related researches and laboratory- acquired infections, and also helps to recommend and develop relevant immune strategy for future vaccine control of such infections.
Contraindications
;
Humans
;
Smallpox Vaccine
;
adverse effects
;
Vaccination
;
standards
;
Vaccinia
;
immunology
;
prevention & control
;
Vaccinia virus
;
immunology
4.The Strategic Plans for Preparedness and Response to Bioterrorism.
Journal of the Korean Medical Association 2002;45(5):597-606
Since bioterrorism has become reality after its occurrence in USA, our goverment is preparing and conducting strategic plans for preparedness and response to bioterrorism. The major plans consist of reinforcement of surveillance of notifiable communicable diseases, construction of supplementary surveillance systems, organization of emergency department and infection specialists networks, strengthening of laboratory capacity and network, and establishment of a stepwise response plan according to risk assessment. For the preparedness for bioterrorism, we are preparing a national pharamaceutical stockpile (antibiotics, smallpox vaccine, etc) and strengthening the organization, law, epidemiologic capacity, research, and management of critical infectious agents. It is very difficult to predict the risk of bioterrorism, which may be very low. Nevertheless, the complete preparedness is necessary to prevent social confusion by bioterrorism. Especially, phisician's role in response to bioterrorism such as case detection, report, management, and treatment is very important.
Bioterrorism*
;
Communicable Diseases
;
Emergency Service, Hospital
;
Jurisprudence
;
Risk Assessment
;
Smallpox Vaccine
;
Specialization
5.Vaccines today, vaccines tomorrow: a perspective.
Clinical and Experimental Vaccine Research 2013;2(1):4-7
Vaccines are considered as one of the major contributions of the 20th century and one of the most cost effective public health interventions. The International Vaccine Institute has as a mission to discover, develop and deliver new and improved vaccines against infectious diseases that affects developing nations. If Louis Pasteur is known across the globe, vaccinologists like Maurice Hilleman, Jonas Salk and Charles Merieux are known among experts only despite their contribution to global health. Thanks to a vaccine, smallpox has been eradicated, polio has nearly disappeared, Haemophilus influenzae B, measles and more recently meningitis A are controlled in many countries. While a malaria vaccine is undergoing phase 3, International Vaccine Institute, in collaboration with an Indian manufacturer has brought an oral inactivated cholera vaccine to pre-qualification. The field of vaccinology has undergone major changes thanks to philanthropists such as Bill and Melinda Gates, initiatives like the Decade of Vaccines and public private partnerships. Current researches on vaccines have more challenging targets like the dengue viruses, malaria, human immunodeficiency virus, the respiratory syncytial virus and nosocomial diseases. Exciting research is taking place on new adjuvants, nanoparticles, virus like particles and new route of administration. An overcrowded infant immunization program, anti-vaccine groups, immunizing a growing number of elderlies and delivering vaccines to difficult places are among challenges faced by vaccinologists and global health experts.
Cholera
;
Communicable Diseases
;
Cooperative Behavior
;
Dengue Virus
;
Developing Countries
;
Haemophilus influenzae
;
HIV
;
Humans
;
Hypogonadism
;
Immunization Programs
;
Infant
;
Malaria
;
Measles
;
Meningitis
;
Missions and Missionaries
;
Mitochondrial Diseases
;
Nanoparticles
;
Ophthalmoplegia
;
Poliomyelitis
;
Public Health
;
Public-Private Sector Partnerships
;
Respiratory Syncytial Viruses
;
Smallpox Vaccine
;
Vaccines
;
Viruses